Optimization of OSCC spheroid generation for high-throughput drug screening

优化 OSCC 球体生成方法以用于高通量药物筛选

阅读:1

Abstract

BACKGROUND: Three-dimensional (3D) spheroid models better replicate the in vivo tumor microenvironment than conventional two-dimensional (2D) cultures, making them valuable tools for preclinical drug screening in oral squamous cell carcinoma (OSCC). METHODS: Scaffold-free spheroids were generated from CAL 27 and OECM-1 OSCC cell lines using three approaches: methylcellulose suspension, agarose-coated plates, and ultra-low attachment (ULA) plates. Spheroid morphology and size uniformity were assessed microscopically. Functional characterization included viability assays and histological evaluation for necrosis. Molecular profiling of cancer hallmark genes was performed using qRT-PCR. Drug response assays for cisplatin and doxorubicin were compared between 2D and 3D cultures. RESULTS: Compact, uniform spheroids (~ 150-200 μm) formed within 72 h in both cell lines, with ULA plates producing the highest reproducibility and structural integrity. Histological analysis revealed central necrosis with viable peripheral cell layers. Gene expression analysis confirmed the modulation of hallmark cancer-associated genes in spheroid associated with hypoxia, angiogenesis, stress-response, adhesion and EMT-related pathways. Drug assays demonstrated significantly higher resistance to cisplatin and doxorubicin in 3D spheroids than in 2D monolayers (p < 0.05). CONCLUSION: ULA-based 3D spheroids provide a reproducible, structurally stable, and scalable model that closely mimics OSCC tumor biology and chemoresistance. These findings support their application as a robust platform for high-throughput drug screening and translational cancer research. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s44164-025-00099-2.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。